EJC Supplements
Volume 5, Issue 2 , Pages 13-22 , July 2007

The need for aminoglycosides in combination with β-lactams for high-risk, febrile neutropaenic patients with leukaemia

  • Lubos Drgona

      Affiliations

    • Department of Internal Medicine, National Cancer Institute, Bratislava, Slovakia
    • ,
  • Mical Paul

      Affiliations

    • Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    • Corresponding Author InformationCorresponding author: Tel.: +972 3 9376504; fax: +972 3 9376512.
    • ,
  • Giampaolo Bucaneve

      Affiliations

    • Department of Internal Medicine, Ospedale Silvestrini, Perugia, Italy
    • ,
  • Thierry Calandra

      Affiliations

    • Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, CH-1011 Lausanne, Switzerland
    • ,
  • Francesco Menichetti

      Affiliations

    • Infectious Diseases Unit, Ospedale Cisanello, Pisa, Italy

Received 14 May 2007 ,Revised 6 June 2007 ,Accepted 11 June 2007.

☆ The ECIL-1 is a common initiative of the following groups or organizations: Infectious Diseases Working Party of the European Blood and Marrow Transplantation Group (EBMT-IDWP), Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), European Leukaemia, Net (ELN) (EU Grant number: LSHC-CT-2004), and International Immunocompromised Host Society (ICHS).

PII: S1359-6349(07)00005-5

doi: 10.1016/j.ejcsup.2007.06.003

EJC Supplements
Volume 5, Issue 2 , Pages 13-22 , July 2007

Article Tools

* Image Usage & Resolution